Table 4.

Pregnancy after hematopoietic-cell transplantation: distribution of age at transplant with dose of total body irradiation, dose of cyclophosphamide during conditioning and diagnosis

Characteristic	Age at HCT in years, N (%)
	<10	10-19	20-29	30-39	≥40
Men who fathered a child after HCT, N
N	3	15	54	20	3
Dose of TBI
No TBI	3 (100)	13 (87)	42 (78)	16 (80)	2 (67)
<400 cGy	0	0	0	0	1 (33)
400-799 cGy	0	1 (7)	2 (4)	0	0
800-1199 cGy	0	1 (7)	8 (15)	4 (20)	0
≥1200 cGy	0	0	2 (4)	0	0
Conditioning regimen cyclophosphamide dose
No cyclophosphamide	0	0	6 (12)	2 (10)	1 (33)
≤120 mg/kg	1 (33)	5 (33)	23 (44)	6 (30)	2 (67)
121-200 mg/kg	1 (33)	8 (53)	20 (38)	12 (60)	0
>200 mg/kg	1 (33)	2 (13)	3 (6)	0	0
Diagnosis
Malignant disorder	1 (33)	6 (40)	40 (74)	15 (75)	3 (100)
Non-malignant disorder	2 (66)	9 (60)	14 (26)	5 (25)	0
Women who reported pregnancy after HCT, N
N	5	36	34	7	0
Dose of TBI
No TBI	3 (60)	33 (92)	28 (82)	6 (86)	0
<400 cGy	0	0	3 (9)	0	0
400-799 cGy	0	1 (3)	0	0	0
800-1199 cGy	1 (20)	2 (6)	3 (9)	1 (14)	0
≥1200 cGy	1 (20)	0	0	0	0
Conditioning regimen cyclophosphamide dose
No cyclophosphamide	0	1 (3)	5 (15)	1 (14)	0
≤120 mg/kg	2 (40)	5 (14)	6 (18)	2 (29)	0
121-200 mg/kg	2 (40)	26 (72)	16 (47)	4 (57)	0
>200 mg/kg	1 (20)	4 (11)	7 (21)	0	0
Diagnosis
Malignant disorder	2 (40)	11 (30)	15 (44)	6 (86)	0
Non-malignant disorder	3 (60)	26 (70)	19 (56)	1 (14)	0